Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Europe’s Medical Marijuana Market Positioned for Explosive Multi-Billion Dollar Growth Through 2034
GlobeNewswire, Inc.
NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Europe’s medical marijuana market has been gaining serious momentum over the past few years, and a lot of that growth is being driven by changing attitudes toward...
Greenland Criticizes US Health Assessment Visit
MENAFN
(MENAFN) Officials in Greenland have criticized the presence of an American doctor accompanying a recent US delegation to Nuuk, arguing that the visit carries political implications tied to Washington’s growing interest in the Arctic territory....
Berry Street Partners with Factor, Bringing Personalized Nutrition Therapy to Leading Meal Delivery Service
GlobeNewswire, Inc.
NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Berry Street, the leading metabolic health company transforming nutrition therapy, and Factor, America’s leading ready-to-heat meal delivery service, today announced a new partnership to provide...
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
GlobeNewswire, Inc.
Q1 2026 product sales of $24.3 million, representing 73% growth over Q1 2025 Raising full year revenue guidance - now expect 2026 revenue to exceed $120 million, up from previous guidance of $110 million Q1 2026 fully diluted GAAP EPS of $0.05,...
Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
GlobeNewswire, Inc.
Company announcement No. 16 / 2026 Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) Copenhagen, Denmark, May 14, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
GlobeNewswire, Inc.
Company to continue development of efzofitimod in pulmonary sarcoidosis following Type C meeting with the FDA. Company plans to submit an IND in June 2026 for a Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary...
Health Experts Highlight 7 Reasons Seniors Should Stay Active
EIN Presswire
Regular activity in senior years supports health, mobility, and independence, making it easier to stay active, social, and live life on your own terms.
MagVenture Launches MagVenture Go™ Portable TMS System to Enhance Clinical Flexibility
EIN Presswire
ALPHARETTA, GA, UNITED STATES, May 13, 2026 /EINPresswire.com/ -- MagVenture, a global leader in non-invasive neuromodulation technology, today announced the launch of the MagVenture Go™ Portable TMS system, a compact and mobile transcranial...
AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
GlobeNewswire, Inc.
CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC...
Challenged Athletes Foundation and Össur Advance Power in Motion with New Sports Prosthetic Grants and Mobility Clinics Nationwide
GlobeNewswire, Inc.
San Diego, CA, May 14, 2026 (GLOBE NEWSWIRE) -- In conjunction with its Annual Grant Distribution and the momentum of Power in Motion, the Challenged Athletes Foundation (CAF) is proud to spotlight one of its longest-standing and most impactful...
Zealand Pharma Announces Financial Results for the First Three Months of 2026
GlobeNewswire, Inc.
Company announcement – No. 14 / 2026 Zealand Pharma Announces Financial Results for the First Three Months of 2026 A defining start to 2026, marked by pivotal progress for leading obesity assets, petrelintide and survodutide, and strong momentum...
Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm
GlobeNewswire, Inc.
TARPON SPRINGS, Fla., May 8, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway...
Shamrock Medicine Expands Family Medicine Services in Philadelphia and Chestnut Hill with Dr. Monalisa Ghose
EIN Presswire
Board-certified family medicine physician Dr. Monalisa Ghose supports Shamrock Medicine’s primary care access for adults in Philadelphia and Chestnut Hill. PHILADELPHIA, PA, UNITED STATES, May 6, 2026 /EINPresswire.com/ -- Shamrock Medicine, an...
VELA Chairs, Parent Company of Enable Me, Named Denmark’s Best Workplace for Second Consecutive Year
EIN Presswire
A 98% employee approval rating and 2026 Great Place to Work® win confirms VELA Chairs’ status as a global leader in quality and workplace excellence.
Zealand Pharma - Execution framework for share buy-back program
GlobeNewswire, Inc.
Company announcement No. 15 / 2026 Zealand Pharma - Execution framework for share buy-back program Copenhagen, Denmark, May 7, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company...
Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program
GlobeNewswire, Inc.
Company announcement No. 13 / 2026 Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program Robust cash position of USD 2.3 billion (DKK 14.5 billion) as of March 31, 2026 Financial strength to be further enhanced by...
Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates
GlobeNewswire, Inc.
SONATA-HCM anticipated to be fully enrolled mid-2026 Resubmission of NDA for ZYNQUISTA® in type 1 diabetes anticipated mid-2026 with potential for approval this year Clinical development of LX9851 initiated by Novo Nordisk Capital raise,...
Ascendis Pharma Reports First Quarter 2026 Financial Results
GlobeNewswire, Inc.
- Q1 2026 revenue of €197 million for YORVIPATH® and €44 million for SKYTROFA® - More than 1,000 new patient enrollments for YORVIPATH in the U.S. in Q1 - As of May 1, more than 60 YUVIWEL® enrollments since early April U.S. commercial launch -...
Gaza: Red Cross Field Hospital in Rafah undergoes overhaul to continue addressing urgent health care needs
International Committee of the Red Cross
“The entry of medical equipment and supplies for the Red Cross Field Hospital is a positive step towards responding to the medical needs of people in Gaza,” said Julien Lerisson, the ICRC’s head of delegation in Israel and the Occupied...
Two years on: upgrading the Red Cross Field Hospital in Rafah
International Committee of the Red Cross
Over the last two years, the Red Cross Field Hospital has been a constant in Gaza's fractured health landscape.
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.